本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

10.85
-0.3550-3.17%
盘前10.870.0200+0.18%04:52 EST
成交量:272.41万
成交额:3,018.75万
市值:9.44亿
市盈率:-4.37
高:11.50
开:11.16
低:10.77
收:11.21
52周最高:16.68
52周最低:5.41
股本:8,701.75万
流通股本:6,398.56万
量比:0.97
换手率:4.26%
股息:- -
股息率:- -
每股收益(TTM):-2.4801
每股收益(LYR):-2.0193
净资产收益率:-65.10%
总资产收益率:-26.57%
市净率:3.89
市盈率(LYR):-5.37

数据加载中...

2020/03/26

重要事件披露

Current report, items 1.01 and 2.03
2020/03/16

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, items 8.01 and 9.01
2020/02/25

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/25

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/23

重要事件披露

Current report, item 5.02
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/10

重要事件披露

Current report, items 1.01 and 2.03
2019/12/17

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/16

重要事件披露

Current report, items 8.01 and 9.01
2019/12/09

重要事件披露

Current report, items 8.01 and 9.01
2019/11/05

季度报告

Quarterly report [Sections 13 or 15(d)]